世界の次世代シーケンシング(NGS)市場(~2026年):製品&サービス別(消耗品、プラットフォーム、サービス、バイオインフォマティクス)、技術別(SBS、SMRT)、用途別(診断、創薬、農業)、エンドユーザー別(製薬、バイオテクノロジー、学術)

調査会社MarketsandMarkets社が発行したリサーチレポート(データ管理コード:BT2697)
◆英語タイトル:Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services, Bioinformatics), Technology (SBS, SMRT), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2026
◆発行会社/調査会社:MarketsandMarkets
◆商品コード:BT2697
◆発行日:2029年4月23日
◆調査対象地域:グローバル
◆産業分野:バイオ
◆ページ数:377
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の次世代シーケンシング(NGS)市場(~2026年):製品&サービス別(消耗品、プラットフォーム、サービス、バイオインフォマティクス)、技術別(SBS、SMRT)、用途別(診断、創薬、農業)、エンドユーザー別(製薬、バイオテクノロジー、学術)]についてメールでお問い合わせはこちら
マーケッツアンドマーケッツ社は、世界の次世代シーケンシング(NGS)市場規模が2021年103億ドルから2026年242億ドルまで、年平均18.7%成長すると予測しています。本調査レポートでは、次世代シーケンシング(NGS)の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品&サービス別(NGS消耗品、シーケンシングサービス、製品・サービス事前調査/サンプル準備、NGSプラットフォーム、バイオインフォマティクス)分析、技術別(SBS、イオン半導体シーケンシング、ナノポアシーケンシング、単一分子リアルタイムシーケンシング、その他)分析、用途別(診断、創薬、農業&動物研究、その他)分析、エンドユーザー別(学術機関&研究センター、製薬&バイオテクノロジー企業、病院&クリニック、その他)分析、地域別分析、競争状況、企業情報などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の次世代シーケンシング(NGS)市場規模:製品&サービス別(NGS消耗品、シーケンシングサービス、製品・サービス事前調査/サンプル準備、NGSプラットフォーム、バイオインフォマティクス)
・世界の次世代シーケンシング(NGS)市場規模:技術別(SBS、イオン半導体シーケンシング、ナノポアシーケンシング、単一分子リアルタイムシーケンシング、その他)
・世界の次世代シーケンシング(NGS)市場規模:用途別(診断、創薬、農業&動物研究、その他)
・世界の次世代シーケンシング(NGS)市場規模:エンドユーザー別(学術機関&研究センター、製薬&バイオテクノロジー企業、病院&クリニック、その他)
・世界の次世代シーケンシング(NGS)市場規模:地域別
・競争状況
・企業情報
*** レポート概要(サマリー)***

“The next-generation sequencing market is projected to reach USD 24.2 billion by 2026 from USD 10.3 billion in 2021, at a CAGR of 18.7% during the forecast period, owing to availability of advanced NGS systems at low costs, and favorable funding scenario for precision medicine.”

“By product & service, the NGS consumables segment accounted for the largest share of the next-generation sequencing market”
The next-generation sequencing market by product is categorized into major consumables and equipments. NGS consumables dominated the market in 2020. The large share of this segment can be attributed to growing number of sequencing procedures and launch of easy-to-use consumables.

“Asia Pacific: The fastest-growing region in the next-generation sequencing market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to increasing number of NGS-based research projects, growing number of cancer cases, and rising awareness about precision medicine.

“North America: the largest share of the next-generation sequencing market”
North America accounted for the largest share of the next-generation sequencing market. Factors such as availability of research funding and the development of NGS data analysis solutions are the major factors driving the market growth.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
By Respondent– Supply Side- 70%, Demand Side- 30%
By Designation— Executives- 25%, CXOs, Directors–30%, Managers – 45%
By Region— North America – 40%, Europe – 25%, APAC – 20%, LATAM- 10%, MEA- 5%

The next-generation sequencing market is dominated by a few globally established players such as Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), GENEWIZ (US), Psomagen, Inc. (South Korea), 10x Genomics (US), Takara Bio (Japan), Zymo Research (US), NuGen Technologies (US), Hamilton Company (US), Beckman Coulter (US), Becton, Dickinson, and Company (US), Lucigen Corporation (US), and Novogene Co., Ltd. (China).

Research Coverage:
The report segments the next-generation sequencing market based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), Product & Service (NGS Consumables, Sequencing Services (Exome & Targeted Resequencing & Custom Panels, Whole-Genome Sequencing & De Novo Sequencing, RNA Sequencing, Other Sequencing Services), Presequencing Products & Services (Library Preparation & Target Enrichment, Quality Control), NGS Platforms (Illumina (Novaseq Systems, Nextseq Systems, Miseq Systems, Miniseq Systems, iSeq Systems), Thermo Fisher Scientifi (ION PGM Systems, ION Proton Systems, ION Genestudio Systems, Ion Torrent Genexus Systems), Oxford Nanopore Technologies, Pacific Biosciences, Other Platforms), Bioinformatics, Services for NGS Platforms), Bioinformatics (Data Analysis Services, NGS Data Analysis Software & Workbenches, NGS Storage, Management, & Cloud Computing Solutions), Technology (Sequencing by Synthesis, ION Semiconductor Sequencing, Nanopore Sequencing, Single-Molecule Real-Time Sequencing, Other Technologies), Application (Diagnostics (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications), Drug Discovery, Agricultural & Animal Research, Other Applications), End User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Other End Users)

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the next-generation sequencing market

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the next-generation sequencing market and provides them information on key market drivers, challenges, and opportunities.

*** レポート目次(コンテンツ)***

1 INTRODUCTION 47
1.1 OBJECTIVES OF THE STUDY 47
1.2 MARKET DEFINITION 47
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 48
1.3 MARKET SCOPE 49
FIGURE 1 NEXT-GENERATION SEQUENCING MARKET SEGMENTATION 49
1.3.1 YEARS CONSIDERED FOR THE STUDY 50
1.4 CURRENCY 50
1.5 LIMITATIONS 50
1.6 STAKEHOLDERS 51
1.7 SUMMARY OF CHANGES 51
2 RESEARCH METHODOLOGY 52
2.1 RESEARCH DATA 52
2.1.1 SECONDARY DATA 52
2.1.2 PRIMARY DATA 53
FIGURE 2 PRIMARY SOURCES 53
FIGURE 3 NEXT-GENERATION SEQUENCING MARKET: BREAKDOWN OF PRIMARIES 54
2.1.2.1 Key industry insights 55
2.2 MARKET SIZE ESTIMATION 56
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020 56
FIGURE 5 AVERAGE MARKET SIZE ESTIMATION, 2020 58
FIGURE 6 NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS,
2021–2026 59
FIGURE 7 NEXT-GENERATION SEQUENCING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 60
FIGURE 8 DATA TRIANGULATION METHODOLOGY 61
2.4 RESEARCH ASSUMPTIONS 61
2.5 RISK ANALYSIS 62
3 EXECUTIVE SUMMARY 63
FIGURE 9 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION) 63
FIGURE 10 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 64
FIGURE 11 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION
2021 VS. 2026 (USD MILLION) 64
FIGURE 12 NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 65
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE NEXT-GENERATION
SEQUENCING MARKET 66
4 PREMIUM INSIGHTS 67
4.1 NEXT-GENERATION SEQUENCING MARKET OVERVIEW 67
FIGURE 14 ADVANCEMENTS IN NGS PLATFORMS TO DRIVE MARKET GROWTH 67
4.2 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020) 68
FIGURE 15 NGS CONSUMABLES SEGMENT ACCOUNTED FOR
THE LARGEST SHARE OF THE NORTH AMERICAN NGS MARKET IN 2020 68
4.3 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 69
FIGURE 16 DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE
THE NGS MARKET IN 2026 69
4.4 NEXT-GENERATION SEQUENCING MARKET SHARE, BY END USER, 2020 70
FIGURE 17 ACADEMIC INSTITUTES & RESEARCH CENTERS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020 70
4.5 NEXT-GENERATION SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 71
FIGURE 18 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE NGS MARKET FROM 2021 TO 2026 71
5 MARKET OVERVIEW 72
5.1 INTRODUCTION 72
5.2 MARKET DYNAMICS 72
FIGURE 19 NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 72
TABLE 1 NEXT-GENERATION SEQUENCING MARKET: IMPACT ANALYSIS 73
5.2.1 DRIVERS 73
5.2.1.1 Advancements in NGS platforms 73
5.2.1.1.1 iSeq 100 System 74
5.2.1.1.2 Ion GeneStudio S5 74
5.2.1.2 Declining costs of genome sequencing 74
FIGURE 20 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2020 74
5.2.1.3 Improving regulatory and reimbursement scenario for NGS-based diagnostic tests 75
5.2.1.4 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research 75
TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2040 75
5.2.2 RESTRAINTS 76
5.2.2.1 End-user budget constraints in developing countries 76
5.2.3 OPPORTUNITIES 76
5.2.3.1 Government & private support for large-scale sequencing 76
TABLE 3 GLOBAL SEQUENCING INITIATIVES 76
5.2.3.2 Application of NGS in precision medicine and molecular diagnostics 77
5.2.3.3 NGS data analysis using big data 77
FIGURE 21 DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING,
2001–2019 77
5.2.4 CHALLENGES 78
5.2.4.1 Interpretation of complex data from NGS platforms 78
5.2.4.2 Ethical issues 79
5.2.4.3 Introduction of alternative technologies 79
5.2.5 INDUSTRY TRENDS 79
5.2.5.1 Development of portable sequencing technologies 79
5.2.5.2 Partnerships & collaborations for technological
advancements in NGS 79
TABLE 4 PARTNERSHIPS & COLLABORATIONS, JANUARY 2018–MARCH 2021 80
5.3 IMPACT OF THE COVID-19 OUTBREAK ON THE NEXT-GENERATION
SEQUENCING MARKET 81
5.4 PORTER’S FIVE FORCES ANALYSIS 83
TABLE 5 NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS 83
5.4.1 THREAT OF NEW ENTRANTS 83
5.4.2 THREAT OF SUBSTITUTES 83
5.4.3 BARGAINING POWER OF SUPPLIERS 83
5.4.4 BARGAINING POWER OF BUYERS 84
5.4.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 84
5.5 VALUE CHAIN ANALYSIS 84
FIGURE 22 VALUE CHAIN ANALYSIS OF THE NEXT-GENERATION SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE 84
FIGURE 23 VALUE CHAIN: NEXT-GENERATION SEQUENCING ANALYSIS WORKFLOW —MAXIMUM VALUE IS ADDED DURING THE SEQUENCING AND ANALYSIS PHASES 85
5.6 TECHNOLOGICAL ANALYSIS 86
TABLE 6 SANGER SEQUENCING VS. NGS 86
5.7 ECOSYSTEM ANALYSIS 87
FIGURE 24 ECOSYSTEM ANALYSIS: NEXT-GENERATION SEQUENCING MARKET 87
TABLE 7 SUPPLY CHAIN ECOSYSTEM 87
5.8 PATENT ANALYSIS 88
FIGURE 25 PATENT APPLICATIONS FOR NEXT-GENERATION SEQUENCING, JANUARY 2010–DECEMBER 2020 88
5.9 PRICING ANALYSIS 89
TABLE 8 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY REGION (2020) 89
5.10 REGULATORY ANALYSIS 89
5.10.1 NORTH AMERICA 89
5.10.1.1 US 89
TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION 90
TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 90
5.10.1.2 Canada 91
5.10.2 EUROPE 91
5.10.3 ASIA PACIFIC 92
5.10.3.1 China 92
TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES 92
5.10.3.2 Japan 92
5.10.3.3 India 93
5.10.4 LATIN AMERICA 93
5.10.5 MIDDLE EAST 93
6 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE 94
6.1 INTRODUCTION 95
TABLE 12 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 95
6.2 NGS CONSUMABLES 95
6.2.1 GROWING NUMBER OF SEQUENCING PROCEDURES TO PROPEL THE DEMAND FOR NGS CONSUMABLES 95
TABLE 13 NGS CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 96
TABLE 14 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 96
TABLE 15 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
TABLE 16 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
TABLE 17 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 98
6.3 SEQUENCING SERVICES 98
TABLE 18 NGS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 98
TABLE 19 SEQUENCING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 99
TABLE 20 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
TABLE 21 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
TABLE 22 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 100
TABLE 23 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 100
6.3.1 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS 100
6.3.1.1 Development of technologically advanced NGS products & services to propel the market growth 100
TABLE 24 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET,
BY REGION, 2019–2026 (USD MILLION) 101
TABLE 25 NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 101
TABLE 26 EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 102
TABLE 27 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 102
TABLE 28 LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 103
6.3.2 WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING 103
6.3.2.1 Reducing whole-genome sequencing costs to propel the growth of this segment 103
TABLE 29 WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET,
BY REGION, 2019–2026 (USD MILLION) 104
TABLE 30 NORTH AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
TABLE 31 EUROPE: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 32 ASIA PACIFIC: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 33 LATIN AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
6.3.3 RNA SEQUENCING 106
6.3.3.1 Launch of advanced RNA products & services to drive market growth 106
TABLE 34 RNA SEQUENCING MARKET, BY REGION, 2019–2026 (USD MILLION) 107
TABLE 35 NORTH AMERICA: RNA SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 107
TABLE 36 EUROPE: RNA SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 107
TABLE 37 ASIA PACIFIC: RNA SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
TABLE 38 LATIN AMERICA: RNA SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
6.3.4 OTHER SEQUENCING SERVICES 108
TABLE 39 OTHER SEQUENCING SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 109
TABLE 40 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 109
TABLE 41 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
TABLE 42 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
TABLE 43 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 111
6.4 PRESEQUENCING PRODUCTS & SERVICES/SAMPLE PREPARATION 111
TABLE 44 PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 111
TABLE 45 PRESEQUENCING PRODUCTS & SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 112
TABLE 46 NORTH AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 112
TABLE 47 EUROPE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 113
TABLE 48 ASIA PACIFIC: PRESEQUENCING PRODUCTS & SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 113
TABLE 49 LATIN AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 114
6.4.1 LIBRARY PREPARATION & TARGET ENRICHMENT 114
6.4.1.1 Development of advanced library preparation solutions to drive market growth 114
TABLE 50 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY REGION, 2019–2026 (USD MILLION) 116
TABLE 51 NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 116
TABLE 52 EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 117
TABLE 53 ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 117
TABLE 54 LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 118
6.4.2 QUALITY CONTROL 118
6.4.2.1 Importance of the quality control step in the NGS workflow is the major factor driving market growth 118
TABLE 55 QUALITY CONTROL MARKET, BY REGION, 2019–2026 (USD MILLION) 118
TABLE 56 NORTH AMERICA: QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 119
TABLE 57 EUROPE: QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 119
TABLE 58 ASIA PACIFIC: QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 119
TABLE 59 LATIN AMERICA: QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 120
6.5 NGS PLATFORMS 120
6.5.1 NGS PLATFORMS MARKET HAS EXPERIENCED A SIGNIFICANT TRANSFORMATION DUE TO THE ENTRY OF NEW PLAYERS 120
TABLE 60 NGS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 61 NGS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION) 121
TABLE 62 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 121
TABLE 63 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 122
TABLE 64 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 122
TABLE 65 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 122
6.5.2 ILLUMINA 123
TABLE 66 ILLUMINA NGS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 67 ILLUMINA NGS PLATFORMS MARKET, BY REGION,
2019–2026 (USD MILLION) 123
6.5.2.1 NovaSeq Systems 124
TABLE 68 NOVASEQ SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 124
6.5.2.2 NextSeq Systems 124
TABLE 69 NEXTSEQ SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 125
6.5.2.3 MiSeq Systems 125
TABLE 70 MISEQ SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 125
6.5.2.4 iSeq 100 Systems 126
TABLE 71 ISEQ 100 SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 126
6.5.3 THERMO FISHER SCIENTIFIC 126
TABLE 72 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
TABLE 73 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION,
2019–2026 (USD MILLION) 127
6.5.4 OXFORD NANOPORE TECHNOLOGIES 127
TABLE 74 OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION) 128
6.5.5 PACIFIC BIOSCIENCES 128
TABLE 75 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION,
2019–2026 (USD MILLION) 129
6.5.6 OTHER NGS PLATFORMS 129
TABLE 76 OTHER NGS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION) 129
6.6 BIOINFORMATICS 130
TABLE 77 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 130
TABLE 78 BIOINFORMATICS MARKET, BY REGION, 2019–2026 (USD MILLION) 130
TABLE 79 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 131
TABLE 80 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 131
TABLE 81 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 131
TABLE 82 LATIN AMERICA: BIOINFORMATICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 132
6.6.1 NGS DATA ANALYSIS SERVICES 132
6.6.1.1 Rising awareness about NGS data analysis services is the major factor supporting market growth 132
TABLE 83 NGS DATA ANALYSIS SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 132
TABLE 84 NORTH AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 133
TABLE 85 EUROPE: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 133
TABLE 86 ASIA PACIFIC: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 134
TABLE 87 LATIN AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 134
6.6.2 NGS DATA ANALYSIS SOFTWARE & WORKBENCHES 134
6.6.2.1 Development of advanced bioinformatics solutions
to drive the growth of this segment 134
TABLE 88 NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2019–2026 (USD MILLION) 135
TABLE 89 NORTH AMERICA: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 135
TABLE 90 EUROPE: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 136
TABLE 91 ASIA PACIFIC: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 136
TABLE 92 LATIN AMERICA: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 137
6.6.3 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS 137
6.6.3.1 Launch of cloud-based solutions to drive the market 137
TABLE 93 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2019–2026 (USD MILLION) 138
TABLE 94 NORTH AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 138
TABLE 95 EUROPE: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 139
TABLE 96 ASIA PACIFIC: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 139
TABLE 97 LATIN AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 140
6.7 SERVICES FOR NGS PLATFORMS 140
6.7.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT MARKET GROWTH 140
TABLE 98 SERVICES FOR NGS PLATFORMS MARKET, BY REGION,
2019–2026 (USD MILLION) 140
TABLE 99 NORTH AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 141
TABLE 100 EUROPE: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
TABLE 101 ASIA PACIFIC: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 102 LATIN AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 142
7 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY 143
7.1 INTRODUCTION 144
TABLE 103 NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY 144
TABLE 104 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 144
7.2 SEQUENCING BY SYNTHESIS 145
7.2.1 SBS TECHNOLOGY ENABLES THE HIGHEST PRODUCTION OF BASE PAIRS IN A SHORT PERIOD OF TIME 145
TABLE 105 SEQUENCING BY SYNTHESIS MARKET, BY REGION,
2019–2026 (USD MILLION) 146
TABLE 106 NORTH AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 146
TABLE 107 EUROPE: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 146
TABLE 108 ASIA PACIFIC: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
TABLE 109 LATIN AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
7.3 ION SEMICONDUCTOR SEQUENCING 147
7.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS ARE SOME OF THE ADVANTAGES OF ION SEMICONDUCTOR SEQUENCING 147
TABLE 110 ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION,
2019–2026 (USD MILLION) 148
TABLE 111 NORTH AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 149
TABLE 112 EUROPE: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 149
TABLE 113 ASIA PACIFIC: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 150
TABLE 114 LATIN AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 150
7.4 NANOPORE SEQUENCING 150
7.4.1 NANOPORE SEQUENCING IS THE ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES 150
TABLE 115 NANOPORE SEQUENCING MARKET, BY REGION, 2019–2026 (USD MILLION) 151
TABLE 116 NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 151
TABLE 117 EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 152
TABLE 118 ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 152
TABLE 119 LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 153
7.5 SINGLE-MOLECULE REAL-TIME SEQUENCING 153
7.5.1 SMRT SEQUENCING PRODUCES RESULTS IN A SHORT TIME AND AT LOWER COSTS 153
TABLE 120 SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION,
2019–2026 (USD MILLION) 154
TABLE 121 NORTH AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 154
TABLE 122 EUROPE: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 155
TABLE 123 ASIA PACIFIC: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 155
TABLE 124 LATIN AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 156
7.6 OTHER SEQUENCING TECHNOLOGIES 156
TABLE 125 OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION,
2019–2026 (USD MILLION) 156
TABLE 126 NORTH AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 157
TABLE 127 EUROPE: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 157
TABLE 128 ASIA PACIFIC: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 158
TABLE 129 LATIN AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 158
8 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION 159
8.1 INTRODUCTION 160
TABLE 130 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 160
8.2 DIAGNOSTICS 160
TABLE 131 NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 132 NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY REGION, 2019–2026 (USD MILLION) 162
TABLE 133 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 162
TABLE 134 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY COUNTRY, 2019–2026 (USD MILLION) 163
TABLE 135 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 163
TABLE 136 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 164
8.2.1 CANCER DIAGNOSTICS 164
8.2.1.1 Growing number of new cancer cases to propel market growth 164
TABLE 137 FUNDING FOR CANCER RESEARCH BY AMERICAN CANCER SOCIETY
(AS OF MARCH 2021) 165
TABLE 138 NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS,
BY REGION, 2019–2026 (USD MILLION) 166
TABLE 139 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 166
TABLE 140 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 167
TABLE 141 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 167
TABLE 142 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 168
8.2.2 INFECTIOUS DISEASE DIAGNOSTICS 168
8.2.2.1 Increasing demand for NGS products for infectious disease diagnostics to drive market growth 168
TABLE 143 NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2019–2026 (USD MILLION) 169
TABLE 144 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY,
2019–2026 (USD MILLION) 169
TABLE 145 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 170
TABLE 146 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 170
TABLE 147 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 171
8.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS 171
8.2.3.1 Increasing awareness about the benefits of NIPT to propel market growth 171
TABLE 148 NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2019–2026 (USD MILLION) 172
TABLE 149 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY,
2019–2026 (USD MILLION) 172
TABLE 150 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 173
TABLE 151 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY,
2019–2026 (USD MILLION) 173
TABLE 152 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY,
2019–2026 (USD MILLION) 174
8.2.4 OTHER DIAGNOSTIC APPLICATIONS 174
TABLE 153 NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 175
TABLE 154 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 175
TABLE 155 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 176
TABLE 156 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 176
TABLE 157 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 177
8.3 DRUG DISCOVERY 177
8.3.1 INCREASING USE OF NGS DURING CLINICAL TRIALS FOR DRUG DISCOVERY TO SUPPORT MARKET GROWTH 177
TABLE 158 NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY,
BY REGION, 2019–2026 (USD MILLION) 178
TABLE 159 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019–2026 (USD MILLION) 178
TABLE 160 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019–2026 (USD MILLION) 179
TABLE 161 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019–2026 (USD MILLION) 179
TABLE 162 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019–2026 (USD MILLION) 180
8.4 AGRICULTURAL & ANIMAL RESEARCH 180
8.4.1 GROWING FUNDING & SUPPORT FOR ANIMAL & PLANT GENOMICS RESEARCH TO DRIVE MARKET GROWTH 180
TABLE 163 NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2019–2026 (USD MILLION) 181
TABLE 164 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY,
2019–2026 (USD MILLION) 181
TABLE 165 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2019–2026 (USD MILLION) 181
TABLE 166 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2019–2026 (USD MILLION) 182
TABLE 167 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY,
2019–2026 (USD MILLION) 182
8.5 OTHER APPLICATIONS 183
TABLE 168 NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION) 183
TABLE 169 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 184
TABLE 170 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 184
TABLE 171 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 185
TABLE 172 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 185
9 NEXT-GENERATION SEQUENCING MARKET, BY END USER 186
9.1 INTRODUCTION 187
TABLE 173 NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 187
9.2 ACADEMIC INSTITUTES & RESEARCH CENTERS 187
9.2.1 DEVELOPMENT OF COST-EFFECTIVE NGS PRODUCTS & SERVICES FOR RESEARCHERS TO PROPEL MARKET GROWTH 187
TABLE 174 NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2019–2026 (USD MILLION) 188
TABLE 175 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY,
2019–2026 (USD MILLION) 188
TABLE 176 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY,
2019–2026 (USD MILLION) 189
TABLE 177 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY,
2019–2026 (USD MILLION) 189
TABLE 178 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY,
2019–2026 (USD MILLION) 190
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 190
9.3.1 GROWING AGREEMENTS & COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMA & BIOTECH COMPANIES TO DRIVE MARKET GROWTH 190
TABLE 179 NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 191
TABLE 180 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2019–2026 (USD MILLION) 191
TABLE 181 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 192
TABLE 182 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2019–2026 (USD MILLION) 192
TABLE 183 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2019–2026 (USD MILLION) 193
9.4 HOSPITALS & CLINICS 193
9.4.1 DEVELOPMENT OF ADVANCED NGS-BASED DIAGNOSTIC SOLUTIONS TO DRIVE THE ADOPTION OF NGS IN HOSPITALS & CLINICS 193
TABLE 184 NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS,
BY REGION, 2019–2026 (USD MILLION) 194
TABLE 185 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 194
TABLE 186 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 195
TABLE 187 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 195
TABLE 188 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 196
9.5 OTHER END USERS 196
TABLE 189 NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS,
BY REGION, 2019–2026 (USD MILLION) 196
TABLE 190 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 197
TABLE 191 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 197
TABLE 192 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER
END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 198
TABLE 193 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER
END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 198

10 NEXT-GENERATION SEQUENCING MARKET, BY REGION 199
10.1 INTRODUCTION 200
TABLE 194 NEXT-GENERATION SEQUENCING MARKET, BY REGION,
2019–2026 (USD MILLION) 200
10.2 NORTH AMERICA 201
FIGURE 26 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT 201
TABLE 195 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 202
TABLE 196 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 202
TABLE 197 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 198 NORTH AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 203
TABLE 199 NORTH AMERICA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 203
TABLE 200 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 203
TABLE 201 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 204
TABLE 202 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 203 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET,
BY END USER, 2019–2026 (USD MILLION) 205
10.2.1 US 205
10.2.1.1 Growing R&D activities in the US to drive market growth 205
TABLE 204 US: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 206
TABLE 205 US: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 206 US: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 207
TABLE 207 US: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 207
TABLE 208 US: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 207
TABLE 209 US: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 208
TABLE 210 US: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 208
TABLE 211 US: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 209
10.2.2 CANADA 209
10.2.2.1 Increasing government initiatives in genomics research will boost the adoption of NGS 209
TABLE 212 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 210
TABLE 213 CANADA: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 214 CANADA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 215 CANADA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 211
TABLE 216 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 211
TABLE 217 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 212
TABLE 218 CANADA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 219 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 213
10.3 EUROPE 213
TABLE 220 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 213
TABLE 221 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 214
TABLE 222 EUROPE: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 223 EUROPE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 224 EUROPE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 215
TABLE 225 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 215
TABLE 226 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 216
TABLE 227 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 228 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 217
10.3.1 GERMANY 217
10.3.1.1 Germany dominates the European next-generation sequencing market 217
TABLE 229 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 218
TABLE 230 GERMANY: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 218
TABLE 231 GERMANY: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 232 GERMANY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 219
TABLE 233 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 219
TABLE 234 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 220
TABLE 235 GERMANY: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 236 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 220
10.3.2 UK 221
10.3.2.1 Favorable funding scenario for genomics research in the country to support the adoption of NGS 221
TABLE 237 UK: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 221
TABLE 238 UK: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 239 UK: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 240 UK: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 222
TABLE 241 UK: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 223
TABLE 242 UK: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 223
TABLE 243 UK: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 224
TABLE 244 UK: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 224
10.3.3 FRANCE 224
10.3.3.1 Government initiatives to support genomics research—a major factor driving market growth in France 224
TABLE 245 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 225
TABLE 246 FRANCE: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 225
TABLE 247 FRANCE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 248 FRANCE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 226
TABLE 249 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 226
TABLE 250 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 227
TABLE 251 FRANCE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 252 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 228
10.3.4 ITALY 228
10.3.4.1 Favorable funding scenario to drive the next-generation sequencing market in Italy 228
TABLE 253 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 229
TABLE 254 ITALY: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 229
TABLE 255 ITALY: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 230
TABLE 256 ITALY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 230
TABLE 257 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 230
TABLE 258 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 231
TABLE 259 ITALY: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 231
TABLE 260 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 232
10.3.5 SPAIN 232
10.3.5.1 Increasing number of conferences focusing on NGS to support market growth in Spain 232
TABLE 261 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 233
TABLE 262 SPAIN: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 233
TABLE 263 SPAIN: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 234
TABLE 264 SPAIN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 234
TABLE 265 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 234
TABLE 266 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 235
TABLE 267 SPAIN: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 268 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 236
10.3.6 NETHERLANDS 236
10.3.6.1 Large number of conferences and workshops focusing on NGS technologies to boost the NGS market in the Netherlands 236
TABLE 269 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 237
TABLE 270 NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 237
TABLE 271 NETHERLANDS: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 238
TABLE 272 NETHERLANDS: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 238
TABLE 273 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 238
TABLE 274 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 239
TABLE 275 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 239
TABLE 276 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION) 239
10.3.7 REST OF EUROPE 240
TABLE 277 ROE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 240
TABLE 278 ROE: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 241
TABLE 279 ROE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 241
TABLE 280 ROE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 241
TABLE 281 ROE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 242
TABLE 282 ROE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 242
TABLE 283 ROE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 243
TABLE 284 ROE: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 243
10.4 ASIA PACIFIC 243
FIGURE 27 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT 244
TABLE 285 APAC: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 245
TABLE 286 APAC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 245
TABLE 287 APAC: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 246
TABLE 288 APAC: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 246
TABLE 289 APAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 246
TABLE 290 APAC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 247
TABLE 291 APAC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 247
TABLE 292 APAC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 248
TABLE 293 APAC: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 248
10.4.1 CHINA 248
10.4.1.1 China to register the highest growth in the APAC NGS market 248
TABLE 294 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 249
TABLE 295 CHINA: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 250
TABLE 296 CHINA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 250
TABLE 297 CHINA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 250
TABLE 298 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 251
TABLE 299 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 251
TABLE 300 CHINA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 252
TABLE 301 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 252
10.4.2 JAPAN 252
10.4.2.1 High incidence of genetic disorders in the country has resulted in the increased adoption of NGS 252
TABLE 302 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 253
TABLE 303 JAPAN: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 254
TABLE 304 JAPAN: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 254
TABLE 305 JAPAN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 254
TABLE 306 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 255
TABLE 307 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 255
TABLE 308 JAPAN: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 256
TABLE 309 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 256
10.4.3 INDIA 256
10.4.3.1 Growing prevalence of target diseases in India to support market growth 256
TABLE 310 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 257
TABLE 311 INDIA: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 258
TABLE 312 INDIA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 258
TABLE 313 INDIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 258
TABLE 314 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 259
TABLE 315 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 259
TABLE 316 INDIA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 260
TABLE 317 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 260
10.4.4 AUSTRALIA 260
10.4.4.1 Increasing use of NGS platforms by academic institutes to propel market growth 260
TABLE 318 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 261
TABLE 319 AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 261
TABLE 320 AUSTRALIA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 262
TABLE 321 AUSTRALIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 262
TABLE 322 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 262
TABLE 323 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 263
TABLE 324 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 263
TABLE 325 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION) 264
10.4.5 REST OF ASIA PACIFIC 264
TABLE 326 ROAPAC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 265
TABLE 327 ROAPAC: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 265
TABLE 328 ROAPAC: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 266
TABLE 329 ROAPAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 266
TABLE 330 ROAPAC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 266
TABLE 331 ROAPAC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 267
TABLE 332 ROAPAC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 267
TABLE 333 ROAPAC: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 268
10.5 LATIN AMERICA 268
TABLE 334 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 268
TABLE 335 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 269
TABLE 336 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 269
TABLE 337 LATIN AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 270
TABLE 338 LATIN AMERICA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 270
TABLE 339 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 270
TABLE 340 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 271
TABLE 341 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 271
TABLE 342 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019–2026 (USD MILLION) 272
10.5.1 BRAZIL 272
10.5.1.1 High prevalence of HIV in Brazil to drive the demand for NGS 272
TABLE 343 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 272
TABLE 344 BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 273
TABLE 345 BRAZIL: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 273
TABLE 346 BRAZIL: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 273
TABLE 347 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 274
TABLE 348 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 274
TABLE 349 BRAZIL: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 275
TABLE 350 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 275
10.5.2 MEXICO 275
10.5.2.1 Economic growth in Mexico to support the growth of the NGS market 275
TABLE 351 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 276
TABLE 352 MEXICO: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 276
TABLE 353 MEXICO: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 276
TABLE 354 MEXICO: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 277
TABLE 355 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 277
TABLE 356 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 277
TABLE 357 MEXICO: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 278
TABLE 358 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 278
10.5.3 REST OF LATIN AMERICA 278
TABLE 359 ROLA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 279
TABLE 360 ROLA: SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 279
TABLE 361 ROLA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 279
TABLE 362 ROLA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 280
TABLE 363 ROLA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 280
TABLE 364 ROLA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 280
TABLE 365 ROLA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 281
TABLE 366 ROLA: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 281
10.6 MIDDLE EAST & AFRICA 281
10.6.1 LAUNCH OF GENOMIC PROGRAMS TO SUPPORT MARKET GROWTH 281
TABLE 367 MEA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 282
TABLE 368 MEA: SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 282
TABLE 369 MEA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 283
TABLE 370 MEA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 283
TABLE 371 MEA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 283
TABLE 372 MEA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 284
TABLE 373 MEA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 284
TABLE 374 MEA: NEXT-GENERATION SEQUENCING MARKET, BY END USER,
2019–2026 (USD MILLION) 285
11 COMPETITIVE LANDSCAPE 286
11.1 OVERVIEW 286
11.2 MARKET EVALUATION FRAMEWORK 286
TABLE 375 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES—MAJOR GROWTH STRATEGY ADOPTED BY MARKET PLAYERS 286
11.3 MARKET SHARE ANALYSIS 287
FIGURE 28 NEXT-GENERATION SEQUENCING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 287
11.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 288
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE NEXT-GENERATION SEQUENCING MARKET 288
11.5 COMPANY EVALUATION QUADRANT 289
11.5.1 STARS 289
11.5.2 EMERGING LEADERS 289
11.5.3 PERVASIVE PLAYERS 289
11.5.4 PARTICIPANTS 289
FIGURE 30 NEXT-GENERATION SEQUENCING MARKET: COMPANY EVALUATION QUADRANT, 2020 290
11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 291
11.6.1 PROGRESSIVE COMPANIES 291
11.6.2 STARTING BLOCKS 291
11.6.3 RESPONSIVE COMPANIES 291
11.6.4 DYNAMIC COMPANIES 291
FIGURE 31 NEXT-GENERATION SEQUENCING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020 292
11.7 COMPANY PRODUCT FOOTPRINT 293
TABLE 376 PRODUCT PORTFOLIO ANALYSIS: NEXT-GENERATION SEQUENCING
MARKET (2020) 293
11.8 COMPANY GEOGRAPHIC FOOTPRINT 294
TABLE 377 GEOGRAPHIC REVENUE MIX: NEXT-GENERATION
SEQUENCING MARKET (2020) 294
11.9 COMPETITIVE SCENARIO 295
11.9.1 NEXT-GENERATION SEQUENCING MARKET: PRODUCT LAUNCHES 295
11.9.2 NEXT-GENERATION SEQUENCING MARKET: DEALS 296

12 COMPANY PROFILES 298
12.1 KEY PLAYERS 298
12.1.1 ILLUMINA, INC. 298
TABLE 378 ILLUMINA: BUSINESS OVERVIEW 298
FIGURE 32 ILLUMINA: COMPANY SNAPSHOT (2020) 299
12.1.2 THERMO FISHER SCIENTIFIC, INC. 308
TABLE 379 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 308
FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 309
12.1.3 BGI GROUP 320
TABLE 380 BGI GROUP: BUSINESS OVERVIEW 320
12.1.4 PERKINELMER 325
TABLE 381 PERKINELMER: BUSINESS OVERVIEW 325
FIGURE 34 PERKINELMER: COMPANY SNAPSHOT (2020) 325
12.1.5 QIAGEN N.V. 329
TABLE 382 QIAGEN: BUSINESS OVERVIEW 329
FIGURE 35 QIAGEN: COMPANY SNAPSHOT (2020) 329
12.1.6 F. HOFFMANN-LA ROCHE AG 337
TABLE 383 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW 337
FIGURE 36 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2020) 337
12.1.7 EUROFINS SCIENTIFIC 342
TABLE 384 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 342
FIGURE 37 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020) 343
12.1.8 AGILENT TECHNOLOGIES, INC. 346
TABLE 385 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW 346
FIGURE 38 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020) 347
12.1.9 PACIFIC BIOSCIENCES 352
TABLE 386 PACIFIC BIOSCIENCES: BUSINESS OVERVIEW 352
FIGURE 39 PACIFIC BIOSCIENCES: COMPANY SNAPSHOT (2020) 352
12.1.10 OXFORD NANOPORE TECHNOLOGIES 357
TABLE 387 OXFORD NANOPORE TECHNOLOGIES: BUSINESS OVERVIEW 357
12.1.11 GENEWIZ (A PART OF BROOKS AUTOMATION) 362
TABLE 388 GENEWIZ: BUSINESS OVERVIEW 362
FIGURE 40 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2020) 363
12.1.12 PSOMAGEN, INC. (FORMERLY KNOWN AS MACROGEN) 365
TABLE 389 PSOMAGEN: BUSINESS OVERVIEW 365
12.1.13 10X GENOMICS 367
TABLE 390 10X GENOMICS: BUSINESS OVERVIEW 367
12.1.14 NUGEN TECHNOLOGIES (A PART OF THE TECAN GROUP) 371
TABLE 391 NUGEN TECHNOLOGIES: BUSINESS OVERVIEW 371
FIGURE 41 TECAN GROUP: COMPANY SNAPSHOT (2020) 372
12.1.15 ZYMO RESEARCH 374
TABLE 392 ZYMO RESEARCH: BUSINESS OVERVIEW 374
12.1.16 TAKARA BIO 376
TABLE 393 TAKARA BIO: BUSINESS OVERVIEW 376
FIGURE 42 TAKARA BIO: COMPANY SNAPSHOT (2021) 376
12.2 OTHER COMPANIES 379
12.2.1 HAMILTON COMPANY 379
12.2.2 BECKMAN COULTER (A SUBSIDIARY OF DANAHER CORPORATION) 380
12.2.3 BECTON, DICKINSON AND COMPANY 382
12.2.4 GENOTYPIC TECHNOLOGY 382
12.2.5 LUCIGEN CORPORATION 383
13 APPENDIX 384
13.1 DISCUSSION GUIDE 384
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 389
13.3 AVAILABLE CUSTOMIZATIONS 391
13.4 RELATED REPORTS 391
13.5 AUTHOR DETAILS 392

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 発電の南アフリカ市場
    Power Generation in South Africa Summary Power Generation in South Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players includi …
  • 先進バイオ燃料の世界市場見通し2017-2023
    According to Stratistics MRC, the Global Advanced Biofuels Market is expected to grow from $8.64 billion in 2016 to reach $99.74 billion by 2023 with a CAGR of 41.8%. Increasing market for renewable energy, encouraging environmental regulations, and growing investments in the market are some of the …
  • プリンタインク検出器の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Printer Ink Detectors Revenue, means the sales value of Printer Ink Detectors This report studies sales (consumption) of Printer Ink Detectors in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countr …
  • 皮膚筋炎(Dermatomyositis):治療薬開発パイプライン動向(2016年下半期版)
    Dermatomyositis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis - Pipeline Review, H2 2016, provides an overview of the Dermatomyositis (Musculoskeletal Disorders) pipeline landscape. Dermatomyositis is a rare inf …
  • 世界のディファレンシャルアセンブリ市場2020年ー2027年:製品タイプ別(スターターモーター、ベベルギア)、車両タイプ別、地域別
    Global Differential Assembly Market is valued approximately USD 22.39billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.5% over the forecast period 2020-2027. Differential assembly is an integral part of the automotive drivetrain, which provides the primary feature …
  • HVAC機器の世界市場
    About HVAC EquipmentHVAC (heating, ventilation, and air conditioning) systems offer ventilation and filtration of air to maintain the thermal balance in residential and non-residential buildings. HVAC systems offer ventilation and filtration of air to maintain the thermal balance in residential and …
  • グリシルレチン酸カリウムの世界及び中国市場 2018年
    The 'Global and Chinese Potassium Glycyrrhetate Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Potassium Glycyrrhetate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pota …
  • 世界のゴム絶縁ホース市場2017
    Rubber Insulated Hose Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, …
  • 紡織業の世界市場
    In this report, the global Textile Manufacturing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Mi …
  • 輸血検査のアメリカ市場2017-2021
    This report provides an overview of the US blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening/NAT tests, as well as test volume and sales forecasts by market segment.Table of ContentsBusiness Environment  1. Ov …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(BT2697 )"世界の次世代シーケンシング(NGS)市場(~2026年):製品&サービス別(消耗品、プラットフォーム、サービス、バイオインフォマティクス)、技術別(SBS、SMRT)、用途別(診断、創薬、農業)、エンドユーザー別(製薬、バイオテクノロジー、学術)" (英文:Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services, Bioinformatics), Technology (SBS, SMRT), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2026)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。